Skip to main content
. Author manuscript; available in PMC: 2014 Sep 16.
Published in final edited form as: Cochrane Database Syst Rev. 2011 May 11;(5):CD003911. doi: 10.1002/14651858.CD003911.pub2

Comparison 4.

Febrile neutropenia

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Any grade: 3 vs 24 hour infusion 2 912 Risk Ratio (IV, Random, 95% CI) 0.06 [0.02, 0.17]
1.1 Breast cancer 1 521 Risk Ratio (IV, Random, 95% CI) 0.07 [0.02, 0.22]
1.2 Ovarian cancer 1 391 Risk Ratio (IV, Random, 95% CI) 0.02 [0.00, 0.36]